北大醫藥(000788.SZ)業績快報:2020年度淨利潤降21.93%至3918.15萬元
格隆匯 4 月 13日丨北大醫藥(000788.SZ)發佈2020年度業績快報,實現營業收入19.77億元,同比下降21.19%;利潤總額5258.10萬元,同比下降20.21%;歸屬於母公司所有者的淨利潤3918.15萬元,同比下降21.93%;基本每股收益0.0657元。
報吿期內公司營業收入及淨利潤雙雙下降,主要因新冠肺炎疫情影響,公司集中在湖北、北京兩地的醫藥商業業務遭受嚴重波及。武漢封城,湖北地區日常門診醫藥配送業務停滯近3個月;北京疫情導致北大國際醫院門急診量和住院量大幅波動,北醫醫藥藥品配送業務受到衝擊,致使公司醫藥商業營業收入及淨利潤分別有所下降。然而在此逆境下,公司主營業務的醫藥工業淨利潤逆勢增長36.35%,重點發展醫藥工業戰略持續彰顯,醫藥工業成為了穩定公司業績的核心動力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.